Justices Urged To Skip Eligibility Case For Blood Test Patents
IP Law 360
AUGUST 9, 2023
Medical testing companies Natera Inc. and Eurofins Viracor LLC told the U.S. Supreme Court Wednesday not to review the invalidation of Stanford University and CareDx patents on a blood test for detecting organ rejection, saying they were correctly found to cover only natural phenomena.
40 
Let's personalize your content